If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
360.60    0.20 (0.06%)
Bid:
360.60
Ask:
361.00
Spread: 0.40 (0.111%)
Market Cap: £1.91b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim Dividend and Enhanced Scrip Alternative

8 Dec 2020 13:15

RNS Number : 9480H
Hammerson PLC
08 December 2020
 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

Hammerson plc

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

8 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124

 

Therefore, 189,816,827 New Shares will be admitted to trading on the London Stock Exchange and 36,013,297 New Shares will be admitted to trading on the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange.

 

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholder-information/general-meeting.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVTPBTTMTJMBLM
Date   Source Headline
23rd May 20243:45 pmRNSDirector/PDMR Shareholding
21st May 20244:15 pmRNSHolding(s) in Company
16th May 20243:30 pmRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSDirector Declaration
25th Apr 20242:00 pmRNSResult of AGM
16th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20244:30 pmRNSHolding(s) in Company
9th Apr 202410:30 amRNSDirector/PDMR Shareholding
28th Mar 20243:15 pmRNSTotal Voting Rights
26th Mar 20243:00 pmRNSDirector/PDMR Shareholding
25th Mar 20249:00 amRNSDividend Currency Conversion Announcement
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202411:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20242:45 pmRNSCompletion of sale of Union Square
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 202410:45 amRNSNotification of Share Repurchase Programme
6th Mar 20243:15 pmRNSHolding(s) in Company
5th Mar 20249:30 amRNSHolding(s) in Company
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSDisposal
1st Feb 202410:30 amRNSNotification of Full Year Results
25th Jan 20249:13 amRNSDirector Declaration
8th Jan 20243:00 pmRNSHolding(s) in Company
27th Dec 202311:00 amRNSDirector Declaration
20th Dec 20239:30 amRNSHolding(s) in Company
19th Dec 202312:00 pmRNSHolding(s) in Company
15th Dec 20235:00 pmRNSHolding(s) in Company
4th Dec 202312:30 pmRNSHolding(s) in Company
30th Nov 20231:30 pmRNSHolding(s) in Company
30th Nov 202310:00 amRNSBlock listing Interim Review
17th Nov 20231:45 pmRNSHolding(s) in Company
19th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20239:00 amRNSDirector/PDMR Shareholding
11th Oct 20233:45 pmRNSDirector/PDMR Shareholding
9th Oct 20234:15 pmRNSDirector/PDMR Shareholding
6th Oct 20234:00 pmRNSDirector/PDMR Shareholding
5th Oct 20234:00 pmRNSDirector/PDMR Shareholding
20th Sep 20239:00 amRNSHolding(s) in Company
8th Sep 20231:10 pmRNSResults of bond tap issuance and tender offer
8th Sep 20231:00 pmRNSFinal Results of Bond Tender Offers
8th Sep 20239:00 amRNSIndicative Results of Bond Tender Offers
5th Sep 20239:00 amRNSHolding(s) in Company
31st Aug 202312:30 pmRNSHammerson Issues £100m Bond Tap

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.